Observational × Urinary Bladder Neoplasms × 1 year × Clear all ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Recruiting
105 enrolled
ORI-EGI-03
Recruiting
450 enrolled
Bladder Bank (a Prospective Banking Study)
Recruiting
1,500 enrolled
UroDNA
Not yet recruiting
25 enrolled
Evaluation for NCI Surgery Branch Clinical Research Protocols
Recruiting
7,000 enrolled
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Recruiting
5,950 enrolled
GUB-BCR-001
Recruiting
1,000 enrolled
Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
Recruiting
1,000 enrolled
MOMENTUM
Recruiting
8,000 enrolled
CONQUER
Enrolling by invitation
2,000 enrolled
GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit
Completed
127 enrolled
OCCURORTW
Recruiting
2,000 enrolled
The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer
Recruiting
60 enrolled
RIVERS
Recruiting
600 enrolled
DP-04
Recruiting
100 enrolled
Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer
Recruiting
400 enrolled
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
Recruiting
500 enrolled
ABLE-41
Terminated
202 enrolled
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
Recruiting
180 enrolled
CISTO2
Recruiting
408 enrolled
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
Recruiting
300 enrolled
A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer
Active not recruiting
450 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
A Diagnostic for the Early Detection of Bladder Cancer
Active not recruiting
173 enrolled
Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.
Recruiting
266 enrolled
Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.
Recruiting
224 enrolled
Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology
Recruiting
254 enrolled
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
Recruiting
1,100 enrolled
iCaRe2
Recruiting
999,999 enrolled
CAMPERR
Recruiting
7,000 enrolled
Lymphedema After Urologic Surgery
Recruiting
400 enrolled
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Recruiting
1,500 enrolled
(CLOCS-2)
Recruiting
2,900 enrolled
Genetic Susceptibility to Bladder Cancer
Active not recruiting
6,086 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
Molecular Analysis Of Bladder Cancer
Active not recruiting
5,000 enrolled
Evaluating Bladder CAREâ„¢, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases
Active not recruiting
80 enrolled
ELEPHAS-02
Recruiting
416 enrolled
ENAiBLE
Not yet recruiting
500 enrolled
BLCCR
Recruiting
4,400 enrolled
QSCO
Completed
50 enrolled
A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing
Active not recruiting
260 enrolled
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
Recruiting
500 enrolled
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
Completed
22 enrolled
DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy
Active not recruiting
320 enrolled
ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
Completed
1 enrolled
BLUSH
Recruiting
300 enrolled
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
Recruiting
25 enrolled
Measuring Surgical Recovery After Radical Cystectomy
Recruiting
2,000 enrolled
CISTO
Active not recruiting
570 enrolled 27 charts